|
|
Zimmer Biomet Holdings Inc (NYSE: ZBH) |
|
|
|
| |
Zimmer Biomet Holdings Inc 's Total Debt to Equity
ZBH's quarterly Total Debt to Equity and Total Debt, Equity growth
Due to net new borrowings of 15.66%, Total Debt to Equity fell to 0.58, below the Zimmer Biomet Holdings Inc 's average Total Debt to Equity.
Within Medical Equipment & Supplies industry in the first quarter 2025, 47 other companies have achieved lower Total Debt to Equity than Zimmer Biomet Holdings Inc in the Q1 2025. While Total Debt to Equity total ranking has deteriorated compared to the fourth quarter 2024 from 995 to 1099 .
Explain Debt to Equity Ratio?
How much Total Debts ZBH´s has?
What are ZBH´s Equity?
|
Select the Comparisons :
|
|
Select the Ratio:
|
|
| ZBH Total Debt to Equity |
(Mar 31 2025)
Q1 |
(Dec 31 2024)
Q4 |
(Sep 30 2024)
Q3 |
(Jun 30 2024)
Q2 |
(Mar 31 2024)
Q1 |
| Y / Y Equity Change |
-1.6 % |
-0.1 % |
-1.08 % |
3 % |
3.69 % |
| Y / Y Total Debt Change |
23.81 % |
7.57 % |
17.66 % |
2.19 % |
0.11 % |
| Total Debt to Equity MRQ |
0.58 |
0.5 |
0.52 |
0.46 |
0.46 |
| ZBH's Total
Ranking |
# 1099 |
# 995 |
# 258 |
# 1261 |
# 1140 |
| Seq. Equity Change |
-0.58 % |
0.75 % |
-2.87 % |
1.14 % |
0.94 % |
| Seq. Total Debt Change |
15.66 % |
-3.82 % |
10.56 % |
0.66 % |
0.49 % |
| Total Debt to Equity first quarter 2025 Company Ranking |
| Within: |
No. |
| Medical Equipment & Supplies Industry |
# 48 |
| Healthcare Sector |
# 133 |
| Overall Market |
# 1099 |
| Total Debt to Equity Statistics |
| High |
Average |
Low |
| 1.19 |
0.72 |
0.27 |
| (Sep 30 2015) |
|
(Dec 31 2013) |
Cumulative Zimmer Biomet Holdings Inc 's Total Debt to Equity
ZBH's Total Debt to Equity for the trailling 12 Months
ZBH Total Debt to Equity |
(Mar 31 2025)
12 Months |
(Dec 31 2024)
12 Months |
(Sep 30 2024)
12 Months |
(Jun 30 2024)
12 Months |
(Mar 31 2024)
12 Months |
| Y / Y Equity TTM Growth |
0.04 % |
1.36 % |
2.33 % |
3.17 % |
2.95 % |
| Y / Y Total Debt TTM Growth |
12.79 % |
6.75 % |
5.17 % |
-0.13 % |
-2.02 % |
| Total Debt to Equity TTM |
0.51 |
0.48 |
0.47 |
0.45 |
0.46 |
| Total Ranking TTM |
# 45
| # 70
| # 61
| # 67
| # 60
|
| Seq. Equity TTM Growth |
-0.4 % |
-0.02 % |
-0.27 % |
0.74 % |
0.91 % |
| Seq. Total Debt TTM Growth |
5.68 % |
1.83 % |
4.23 % |
0.55 % |
0.03 % |
On the trailing twelve months basis Due to the net new borrowings of 15.66% during the trailing twelve months finishing in the Q1 2025, cumulativeTotal Debt to Equity improved to 0.51, below the Zimmer Biomet Holdings Inc 's average Total Debt to Equity. Total Debt to Equity is the average cumulative value over the last four quarters.
Among companies in the Medical Equipment & Supplies industry 3, during the past 12 months, other companies have achieved lower Total Debt to Equity than Zimmer Biomet Holdings Inc . While Total Debt to Equity total ranking has improved so far to 45, from total ranking in previous 12 month period at 70.
Explain Debt to Equity Ratio?
How much Total Debts ZBH´s has?
What are ZBH´s Equity?
| TTM Total Debt to Equity Company Ranking |
| Within: |
No. |
| Within the Medical Equipment & Supplies Industry |
# 4 |
| Healthcare Sector |
# 14 |
| Within the Market |
# 45 |
| trailing twelve months Total Debt to Equity Statistics |
| High |
Average |
Low |
| 1.01 |
0.61 |
0.09 | | (Dec 31 2017) |
|
(Jun 30 2017) |
| Companies with similar Total Debt to Equity in the quarter ending Mar 31 2025, within Medical Equipment & Supplies Industry | Total Debt to Equity | Mar 31 2025 MRQ Total Debt | Mar 31 2025 MRQ Equity | | Cerus Corporation | 1.53 | $ 84.973 Millions | $ 55.492 Millions | | Haemonetics Corporation | 1.49 | $ 1,224.788 Millions | $ 820.836 Millions | | Adagio Medical Holdings inc | 1.42 | $ 17.652 Millions | $ 12.399 Millions | | Neuronetics Inc | 1.40 | $ 55.341 Millions | $ 39.531 Millions | | Insulet Corporation | 1.27 | $ 1,695.400 Millions | $ 1,330.700 Millions | | Sanara Medtech Inc | 1.22 | $ 44.571 Millions | $ 36.668 Millions | | Dentsply Sirona Inc | 1.16 | $ 2,335.000 Millions | $ 2,010.000 Millions | | Integra Lifesciences Holdings Corp | 1.12 | $ 1,702.440 Millions | $ 1,524.139 Millions | | Dexcom Inc | 1.08 | $ 2,443.300 Millions | $ 2,266.600 Millions | | Artivion Inc | 1.07 | $ 314.746 Millions | $ 294.252 Millions | | Cytosorbents Corporation | 0.98 | $ 14.187 Millions | $ 14.543 Millions | | Conmed Corporation | 0.91 | $ 892.157 Millions | $ 977.636 Millions | | Orchestra Biomed Holdings Inc | 0.85 | $ 14.338 Millions | $ 16.857 Millions | | Icu Medical Inc | 0.77 | $ 1,536.378 Millions | $ 1,987.689 Millions | | Integer Holdings Corporation | 0.77 | $ 1,235.215 Millions | $ 1,606.704 Millions | | Bausch and Lomb Corp | 0.75 | $ 4,829.000 Millions | $ 6,433.000 Millions | | Henry Schein Inc | 0.73 | $ 2,891.000 Millions | $ 3,954.000 Millions | | Cvrx inc | 0.71 | $ 49.332 Millions | $ 69.360 Millions | | Cadre Holdings inc | 0.69 | $ 220.514 Millions | $ 317.562 Millions | | Masimo Corp | 0.67 | $ 636.000 Millions | $ 946.400 Millions | | Seastar Medical Holding Corporation | 0.64 | $ 0.363 Millions | $ 0.565 Millions | | Livanova Plc | 0.61 | $ 628.793 Millions | $ 1,034.298 Millions | | Semler Scientific inc | 0.59 | $ 96.095 Millions | $ 161.683 Millions | | Invo Fertility Inc | 0.59 | $ 1.966 Millions | $ 3.335 Millions | | Zimmer Biomet Holdings Inc | 0.58 | $ 7,176.300 Millions | $ 12,403.800 Millions | | Zimvie Inc | 0.56 | $ 220.618 Millions | $ 395.123 Millions | | Outset Medical Inc | 0.55 | $ 94.115 Millions | $ 169.868 Millions | | Enovis Corp | 0.53 | $ 1,387.565 Millions | $ 2,620.218 Millions | | Infusystem Holdings Inc | 0.52 | $ 28.707 Millions | $ 55.148 Millions | | Pro dex Inc | 0.52 | $ 18.289 Millions | $ 35.282 Millions |
|
